SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-014452
Filing Date
2021-04-01
Accepted
2021-04-01 19:49:41
Documents
1
Period of Report
2021-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9456
  Complete submission text file 0000899243-21-014452.txt   10934
Mailing Address 11682 EL CAMINO REAL, SUITE 320 SAN DIEGO CA 92130
Business Address
Fuglesang Christopher (Reporting) CIK: 0001465835 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39381 | Film No.: 21800133

Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Issuer) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations